ABHD3 (abhydrolase domain containing 3) belongs to the uncharacterized protein family called UPF0017. This protein contains a/ß hydrolase fold, which is a catalytic domain found in multiple proteins. This gene is located at chromosome 18q11.1 and spans 54kb. ABHD3 shares high sequence similarity to ABHD1, and contains a single transmembrane domain at its N-terminal. This protein is expressed in the lung tissue.
Synonyms: Anti-Abhydrolase domain-containing protein 3; Anti-Lung alpha/beta hydrolase 3
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: The function of ABHD3 (abhydrolase domain containing 3) is yet to be characterized. However, studies suggest that this protein might function as a lipase, with specificity for medium-chain and oxidatively truncated phospholipids.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC